Physician profile
Bryan V Fallis
NPI 1083606974
$2,931.36
in general payments reported to CMS, 2019-2025
19 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $180 · 2021: $493 · 2022: $297 · 2023: $700 · 2024: $387 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,564.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,823.35 | 2019-2025 | Viaflow, Easyfuse, Augment Injectable |
| Treace Medical Concepts, INC. | $254.73 | 2022-2025 | |
| Integra Lifesciences Corporation | $152.09 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Avinger INC. | $132.86 | 2021 | |
| Paragon 28, INC. | $85.31 | 2019-2022 | |
| Smith+Nephew, INC. | $70.90 | 2019-2023 | Na |
| Melinta Therapeutics, LLC | $64.54 | 2019 | |
| Bone Support INC. | $52.53 | 2024 | Cerament G, Ceramentbone Void Filler |
| Misonix INC | $49.45 | 2020 | |
| Acera Surgical, INC. | $43.67 | 2024-2025 | Restrata Wound Matrix |
| Medtronic, INC. | $42.67 | 2021-2023 | Intellis Adaptivestim |
| Legacy Ortho LLC | $29.85 | 2023 | |
| Paratek Pharmaceuticals, INC. | $27.39 | 2022-2024 | Nuzyra |
| Wright Medical Technology, INC. | $23.52 | 2020 | |
| Zimmer Biomet Holdings, INC. | $19.44 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $18.36 | 2025 | Novosorb Btm |
| Arthrosurface Incorporated | $14.68 | 2019 | |
| Horizon Therapeutics Plc | $13.69 | 2021 | |
| Bioventus LLC | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Fallis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.